← All trials
NCT00147368
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2005
- Primary completion
- Apr 1, 2006
- Completion date
- Dec 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 50
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Menzies School of Health ResearchLead sponsor
- Wellcome TrustCollaborator
- National Health and Medical Research Council, AustraliaCollaborator
- Rumah Sakit Mitra Masyarakat HospitalCollaborator
- Marquette UniversityCollaborator
- National Institute of Health Research and Development, Jakarta, IndonesiaCollaborator
- Marquette UniversityOverall official - principal investigator
- University of UtahCollaborator
- University of SydneyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.